Climate change and increased urbanisation are posing new challenges to animal disease prevention and control.
GLOBAL ANIMAL HEALTH company Merial and the Australian company Imugene have signed a comprehensive agreement allowing Merial to obtain exclusive rights to Imugene vector technology.
Alain Charles Publishing
University House,
11-13 Lower Grosvenor Place,
London, SW1W 0EX, UK
T: +44 20 7834 7676
F: +44 20 7973 0076
W: www.alaincharles.com